Radiation oncology. Programs for the present and future.
Radiation oncology in 1984 continues to make major advances in the multidisciplinary clinical programs. This has been possible by virtue of the radiation oncologist, who is an active participant in these clinical programs. The changing role for the radiation oncologist has dictated a greater participation in the primary management of the patient's disease process and also participation in multidisciplinary research programs.
D001943:Breast Neoplasms / Q000401:mortality / Q000532:radiotherapy; D002830:Choroid Neoplasms / Q000401:mortality / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000639:trends*; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D011471:Prostatic Neoplasms / Q000401:mortality / Q000532:radiotherapy; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D011877:Radionuclide Imaging; D011879:Radiotherapy Dosage; D012306:Risk; D014481:United States; D014916:Whole-Body Irradiation
D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents